Generated August 2026 from current fund data.
Overview
SPY is the largest and oldest S&P 500 tracker, a broad market ETF that holds the 500 largest U.S. companies and aims to replicate the index before expenses. YSPY is a recently launched derivatives-based income fund that holds SPY but generates income by selling weekly options against SPY and holding exposure to a 3x leveraged S&P 500 ETF (SPXL). The critical difference: SPY delivers market returns with minimal drag, while YSPY pursues income through options selling and leverage, fundamentally changing both return profile and risk.
How they differ
SPY tracks the S&P 500 directly with a 0.10% expense ratio and offers modest 0.98% annual yield from dividends; YSPY wraps SPY in a weekly options-selling strategy layered with 3x leveraged equity exposure, targeting 12.26% distribution rate but charging 1.15% in fees. SPY distributes quarterly from ordinary dividends; YSPY distributes weekly, sourcing income from option premium and return-of-capital treatment. The structural gap widens in volatility: SPY has a beta of 1.0 (market-tracking), while YSPY's beta of 1.36 reflects leverage and options-driven volatility amplification. SPY's $812B in AUM dwarfs YSPY's $10.2M, a 79-fold difference that signals SPY's institutional entrenchment versus YSPY's brand-new, illiquid status (inception February 2025).
Who each is best for
SPY: Fits investors seeking broad U.S. equity exposure with minimal cost, who are willing to accept market-level returns and view equities as long-term capital appreciation vehicles rather than income sources.
YSPY: Designed for tactical income-focused investors with moderate risk tolerance who understand options mechanics, accept NAV erosion as a trade-off for weekly cash flow, and have the time horizon to weather leveraged drawdowns in choppy markets.
Key risks to know
- NAV erosion at elevated yields. A 12.26% annualized distribution rate on a $15 share price implies YSPY is returning over 8% of its net asset value per year from non-fundamental sources (option premium and leverage roll costs). This structure typically erodes NAV over time unless underlying holdings appreciate sharply or options decay less than expected.
- Options-selling tail risk. Selling weekly options on a leveraged ETF (SPXL) caps upside during rallies and locks in losses during sharp declines. If the S&P 500 drops 10%+ suddenly, short option positions can blow out faster than long equity positions can offset losses, magnifying drawdowns.
- Leverage amplification. The embedded 3x leveraged ETF exposure means YSPY's NAV moves roughly 36% more than SPY in either direction. A 10% S&P 500 decline can translate to a 36% NAV hit before considering option losses, making multi-month recovery from crashes slower and deeper.
- Minimal liquidity and price discovery. At $10.2M in AUM, YSPY has negligible trading volume compared to SPY's liquid market. Bid-ask spreads are likely wide, and exit during stress periods may force significant price concessions.
- Structural fund design risk. YSPY is a 3-month-old fund using an untested options-income overlay on leveraged equity. Real-world performance in a rising-rate, volatile environment is unknown; the fund may not behave as modeled during market dislocations.
Bottom line
SPY offers transparent, low-cost index exposure for investors building wealth over decades; YSPY chases higher current income by selling optionality and embracing leverage, accepting NAV decay and tail risk for weekly distributions. If you want predictable market participation with minimal fees, SPY is the straightforward choice. If you're drawn to double-digit yields, understand that those distributions likely depend on capital erosion and must verify you can tolerate the leveraged volatility YSPY introduces. Past performance does not predict future results, and YSPY's 3-month track record offers no insight into behavior during material market stress.
AI-generated analysis for educational purposes only. Verify important details independently; past performance does not guarantee future results.